Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

PharmaSurgics receives Swedish approval to initiate phase I clinical program for PXL-01

Jan. 26, 2009

Stelara receives approval in Europe for moderate to severe plaque psoriasis

Jan. 23, 2009

Remitch approved in Japan for improvement of pruritus in hemodialysis patients

Jan. 22, 2009

Clinuvel reports positive phase III interim results for afamelanotide in EPP

Jan. 22, 2009

CRTH2 inhibitor from Actimis active in model of allergic skin inflammation

Jan. 20, 2009

Repigmentation of vitiligo seen with tacrolimus 0.1% cream

Jan. 16, 2009

ZymoGenetics divulges novel antipsoriatic ztnfr14 antagonists

Jan. 14, 2009

RegeneRx reports phase II RGN-137 results in chronic pressure ulcers

Jan. 12, 2009

FDA extends PDUFA action date for Ipsen's Reloxin BLA for glabellar lines

Jan. 12, 2009

Sinclair and Graceway sign U.S. agreement for Atopiclair for atopic dermatitis

Jan. 12, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...